Shanghai Haohai Biological Technology Co., Ltd. (6826.HK)
6826.HK Stock Price Chart
Explore Shanghai Haohai Biological Technology Co., Ltd. interactive price chart. Choose custom timeframes to analyze 6826.HK price movements and trends.
6826.HK Company Profile
Discover essential business fundamentals and corporate details for Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Apr 2015
Employees
2.16K
Website
https://www.3healthcare.comCEO
Yongtai Hou
Description
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, the United States, the United Kingdom, and internationally. It offers ophthalmology products comprising intraocular lens, ophthalmic viscoelastic devices, orthokeratology and phakic refractive lenses, eye drops, injectors, scalpels, etc.; orthopedics products, such as sodium hyaluronate injection and medical chitosan; wound repair products, including recombinant human epidermal growth factor for the treatment of burn wound, residual wound, donor site posttraumatic wound, and fresh or old wound of chronic ulcer; anti-adhesion materials comprising medical sodium hyaluronate gel and medical chitosan; and hemostatic materials, such as collagen sponge and porcine fibrin sealants. The company also provides medical aesthetics products comprising Matrifill, a first-generation HA dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; and radio frequency devices and laser equipment. In addition, it is involved in research and development of biological engineering and pharmaceutical products, as well as in the provision of related technology transfer, and consultation services; and investment and trading business. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.
6826.HK Financial Timeline
Browse a chronological timeline of Shanghai Haohai Biological Technology Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 5 Sept 2025
A dividend of $0.44 per share was announced, adjusted to $0.44. The dividend will be paid on 17 Oct 2025.
Earnings released on 22 Aug 2025
Dividend declared on 17 Jun 2025
A dividend of $0.66 per share was announced, adjusted to $0.66. The dividend was paid on 18 Jul 2025.
Earnings released on 25 Apr 2025
EPS came in at $0.42 , while revenue for the quarter reached $660.05M .
Earnings released on 20 Feb 2025
EPS came in at $0.26 , while revenue for the quarter reached $662.58M .
Earnings released on 25 Oct 2024
EPS came in at $0.36 , while revenue for the quarter reached $741.80M .
Dividend declared on 20 Sept 2024
A dividend of $0.44 per share was announced, adjusted to $0.44. The dividend was paid on 25 Oct 2024.
Earnings released on 17 Aug 2024
EPS came in at $0.88 , while revenue for the quarter reached $814.50M .
Dividend declared on 6 Jun 2024
A dividend of $1.54 per share was announced, adjusted to $1.10. The dividend was paid on 19 Jul 2024.
Stock split effective on 6 Jun 2024
Shares were split 7 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Apr 2024
EPS came in at $0.63 , while revenue for the quarter reached $698.90M .
Earnings released on 23 Feb 2024
EPS came in at $0.58 , while revenue for the quarter reached $722.88M , missing expectations by -2.22%.
Earnings released on 26 Oct 2023
EPS came in at $0.76 , while revenue for the quarter reached $725.14M .
Earnings released on 18 Aug 2023
EPS came in at $0.78 , while revenue for the quarter reached $751.00M , beating expectations by +3.72%.
Dividend declared on 4 Jul 2023
A dividend of $0.44 per share was announced, adjusted to $0.32. The dividend was paid on 11 Aug 2023.
Earnings released on 29 Apr 2023
EPS came in at $0.54 , while revenue for the quarter reached $697.73M .
Earnings released on 28 Feb 2023
EPS came in at $0.12 , while revenue for the quarter reached $593.24M .
Earnings released on 28 Oct 2022
EPS came in at $0.58 , while revenue for the quarter reached $687.99M .
Earnings released on 27 Aug 2022
EPS came in at $0.24 , while revenue for the quarter reached $559.73M .
Dividend declared on 29 Jul 2022
A dividend of $0.82 per share was announced, adjusted to $0.59. The dividend was paid on 26 Aug 2022.
Earnings released on 30 Apr 2022
EPS came in at $0.25 , while revenue for the quarter reached $589.26M .
Earnings released on 28 Feb 2022
EPS came in at $0.29 , while revenue for the quarter reached $581.95M .
Earnings released on 29 Oct 2021
EPS came in at $0.54 , while revenue for the quarter reached $510.89M .
Earnings released on 26 Aug 2021
EPS came in at $0.78 , while revenue for the quarter reached $507.79M .
Dividend declared on 15 Jul 2021
A dividend of $0.61 per share was announced, adjusted to $0.43. The dividend was paid on 10 Aug 2021.
Earnings released on 24 Apr 2021
EPS came in at $0.77 , while revenue for the quarter reached $500.83M .
Earnings released on 25 Feb 2021
EPS came in at $0.57 , while revenue for the quarter reached $451.75M .
Earnings released on 31 Dec 2020
EPS came in at $0.81 , while revenue for the quarter reached $513.38M .
6826.HK Stock Performance
Access detailed 6826.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.